J&J has struck a deal with Chinese biotech company Genscript, giving it entry to the global market for CAR-T therapies. Despite success in haemato-oncology with drugs such as Imbruvica and Darzalex, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results